News

Constellation Brands (NYSE: STZ) and Altria (NYSE: MO) are both often considered stable blue chip stocks for income investors ...
The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...
R.J. Reynolds Vapor Co.’s Vuse remains the top-selling e-cigarette brand with a 34.9% market share, while Geek Bar Pule by ...
The Food and Drug Administration authorized four of Altria’s menthol e-cigarettes for sale in the country on Friday, making them the first ever flavored vapes the agency has permitted on the market.
Altria Group MO-3.01%decrease; red down pointing triangle has submitted a premarket tobacco product application for its on! Plus oral nicotine pouches to the Food and Drug Administration. The ...
Bullish news It's definitely bullish news for Altria that the company just received Food and Drug Administration (FDA) authorization for the marketing of four menthol-flavored e-vapor products.
Tobacco giant Altria said on Wednesday it had submitted Premarket Tobacco Product Applications (PMTAs) to the U.S. Food and Drug Administration for its on! Plus oral nicotine pouch products.
On Wednesday, the Supreme Court handed down a ruling in a case involving flavored vapes sold by companies like Altria. The judges reversed an appeals court decision that the Food and Drug ...
Marlboro maker Altria Group Inc. is calling on the US Food and Drug Administration to do more to crack down on the illegal vape products that compete with its own authorized product, NJOY.
Altria, meanwhile, expects to file with the Food and Drug Administration for preliminary permission to market a Marlboro-based stick for the partnership’s devices in the first half of 2025 ...
Marlboro maker Altria said on Wednesday it had sent data to the U.S. Food and Drug Administration on growth in illegal nicotine pouches, saying it echoed the early stages of a now massive black ...
Tobacco giant Altria Group has stopped selling its NJOY Ace e-cigarettes, after the U.S. International Trade Commission sided with rival Juul Labs in a patent dispute.